| 1 |
32810299 | Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling. | 2021 Feb |
1 |
| 2 |
33260070 | Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma. | 2021 Jan |
1 |
| 3 |
33744298 | A Potent and Selective Kallikrein-5 Inhibitor Delivers High Pharmacological Activity in Skin from Patients with Netherton Syndrome. | 2021 Sep |
2 |
| 4 |
32472705 | Successful treatment with dupilumab of an adult with Netherton syndrome. | 2020 Oct |
1 |
| 5 |
32606974 | A Novel Tumor Suppressor SPINK5 Serves as an Independent Prognostic Predictor for Patients with Head and Neck Squamous Cell Carcinoma. | 2020 |
3 |
| 6 |
30390391 | Activography reveals aberrant proteolysis in desquamating diseases of differing backgrounds. | 2019 Jan |
1 |
| 7 |
31501002 | TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes. | 2019 Oct |
1 |
| 8 |
17989726 | Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients. | 2008 May |
5 |
| 9 |
15942217 | Netherton syndrome with extensive skin peeling and failure to thrive due to a homozygous frameshift mutation in SPINK5. | 2005 |
2 |
| 10 |
15304086 | SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. | 2004 Sep |
3 |
| 11 |
11511292 | The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. | 2001 Aug |
2 |
| 12 |
11544479 | Gene polymorphism in Netherton and common atopic disease. | 2001 Oct |
2 |
| 13 |
10835624 | Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. | 2000 Jun |
1 |